Table 1 Expression of EBAG9 and 22-1-1 on cancer cell lines.
From: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
Cell line | Origin | 22-1-1 expression Flow cytometry | EBAG9 expression Immunoblot |
|---|---|---|---|
MCF-7 | breast carcinoma | ++ | +++ |
K562 | chronic myelogenous leukemia | - | +++ |
Jurkat | T cell leukemia | +++ | +++ |
Colo-205 | colorectal carcinoma | - | +++ |
SiSo | cervix carcinoma | + | +++ |
CAL-51 | breast carcinoma | - | +++ |
T-47D | breast carcinoma | - | +++ |
ZR-75-1 | breast carcinoma | - | +++ |
HBL-100 | breast carcinoma | - | +++ |
U-266 | multiple myeloma | - | ++ |
CaCo-2 | colon carcinoma | - | ++ |
MDA-MB-461 | breast carcinoma | - | + |
HEK293 A | embryonal kidney | - | + |
U-373 | glioblastoma-astrocytoma | - | + |
L-1236 | Hodgkin's lymphoma | - | + |
H-184 A1 | normal breast | - | + |
SW-480 | colon carcinoma | - | + |
MDA-MB-468 | breast carcinoma | - | + |